Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Autoimmune-Mediated Vasculopathy

Identifieur interne : 001138 ( Main/Exploration ); précédent : 001137; suivant : 001139

Autoimmune-Mediated Vasculopathy

Auteurs : Weiran Chen ; Christopher J. Thoburn ; Yuji Miura ; Matthias Sommer ; Ralph Hruban ; Zhiping Qian ; William Baldwin ; Allan D. Hess

Source :

RBID : ISTEX:42BD07AF7966E59DF1A7C5E2A04236F1F462F8EF

English descriptors

Abstract

Abstract: The use of the immunosuppressive drug cyclosporine A (CsA) in solid organ transplantation can be associated with the development of vasculopathy as part of the complex immune response involved in chronic rejection, including autoimmune recognition. Although CsA can directly affect endothelial cells, this drug alters the T cell repertoire promoting autoimmune recognition. The present studies evaluated the ability of CsA-induced autoreactive T cells to mediate vascular lesions in syngeneic heart grafts. Graft vasculopathy developed in syngeneic heart grafts following either the primary induction of autoimmunity with CsA or the adoptive transfer of CsA-induced autoreactive T cells. Initially, an inflammatory response occurred in the medial wall of the small arterial vessels, accompanied by a perivascular lymphocytic infiltrate (including a lymphocytic infiltrate into the myocardium), followed by progression of vascular disease with endothelial cell proliferation. The development and progression of vascular disease correlated with the cytokine profile of the infiltrating lymphocytes with type 1 cytokines detected early and type 2 cytokines detected as the disease progressed. Initiation of this response correlated with upregulation of the target antigen recognized by the CsA-induced autoreactive T cells, the MHC class II–invariant chain peptide complex. This antigen complex, when upregulated on endothelial cells by interferon, allowed effective targeting by the autoreactive T lymphocytes. Strategies to inhibit the upregulation of MHC class II antigens by treatment of the recipients with chloroquine truncated the disease process. The results of these studies suggest that CsA-induced autoreactive mechanisms can contribute to the development of graft vasculopathy.

Url:
DOI: 10.1006/clim.2001.5038


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Autoimmune-Mediated Vasculopathy</title>
<author>
<name sortKey="Chen, Weiran" sort="Chen, Weiran" uniqKey="Chen W" first="Weiran" last="Chen">Weiran Chen</name>
</author>
<author>
<name sortKey="Thoburn, Christopher J" sort="Thoburn, Christopher J" uniqKey="Thoburn C" first="Christopher J." last="Thoburn">Christopher J. Thoburn</name>
</author>
<author>
<name sortKey="Miura, Yuji" sort="Miura, Yuji" uniqKey="Miura Y" first="Yuji" last="Miura">Yuji Miura</name>
</author>
<author>
<name sortKey="Sommer, Matthias" sort="Sommer, Matthias" uniqKey="Sommer M" first="Matthias" last="Sommer">Matthias Sommer</name>
</author>
<author>
<name sortKey="Hruban, Ralph" sort="Hruban, Ralph" uniqKey="Hruban R" first="Ralph" last="Hruban">Ralph Hruban</name>
</author>
<author>
<name sortKey="Qian, Zhiping" sort="Qian, Zhiping" uniqKey="Qian Z" first="Zhiping" last="Qian">Zhiping Qian</name>
</author>
<author>
<name sortKey="Baldwin, William" sort="Baldwin, William" uniqKey="Baldwin W" first="William" last="Baldwin">William Baldwin</name>
</author>
<author>
<name sortKey="Hess, Allan D" sort="Hess, Allan D" uniqKey="Hess A" first="Allan D." last="Hess">Allan D. Hess</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:42BD07AF7966E59DF1A7C5E2A04236F1F462F8EF</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1006/clim.2001.5038</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-SW245SRF-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000889</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000889</idno>
<idno type="wicri:Area/Istex/Curation">000869</idno>
<idno type="wicri:Area/Istex/Checkpoint">000340</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000340</idno>
<idno type="wicri:doubleKey">1521-6616:2001:Chen W:autoimmune:mediated:vasculopathy</idno>
<idno type="wicri:Area/Main/Merge">001150</idno>
<idno type="wicri:Area/Main/Curation">001138</idno>
<idno type="wicri:Area/Main/Exploration">001138</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Autoimmune-Mediated Vasculopathy</title>
<author>
<name sortKey="Chen, Weiran" sort="Chen, Weiran" uniqKey="Chen W" first="Weiran" last="Chen">Weiran Chen</name>
<affiliation>
<wicri:noCountry code="subField">21231</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Thoburn, Christopher J" sort="Thoburn, Christopher J" uniqKey="Thoburn C" first="Christopher J." last="Thoburn">Christopher J. Thoburn</name>
<affiliation>
<wicri:noCountry code="subField">21231</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Miura, Yuji" sort="Miura, Yuji" uniqKey="Miura Y" first="Yuji" last="Miura">Yuji Miura</name>
<affiliation>
<wicri:noCountry code="subField">21231</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Sommer, Matthias" sort="Sommer, Matthias" uniqKey="Sommer M" first="Matthias" last="Sommer">Matthias Sommer</name>
<affiliation>
<wicri:noCountry code="subField">21231</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Hruban, Ralph" sort="Hruban, Ralph" uniqKey="Hruban R" first="Ralph" last="Hruban">Ralph Hruban</name>
<affiliation>
<wicri:noCountry code="subField">21231</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Qian, Zhiping" sort="Qian, Zhiping" uniqKey="Qian Z" first="Zhiping" last="Qian">Zhiping Qian</name>
<affiliation>
<wicri:noCountry code="subField">21231</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Baldwin, William" sort="Baldwin, William" uniqKey="Baldwin W" first="William" last="Baldwin">William Baldwin</name>
<affiliation>
<wicri:noCountry code="subField">21231</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Hess, Allan D" sort="Hess, Allan D" uniqKey="Hess A" first="Allan D." last="Hess">Allan D. Hess</name>
<affiliation>
<wicri:noCountry code="subField">21231</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Clinical Immunology</title>
<title level="j" type="abbrev">YCLIM</title>
<idno type="ISSN">1521-6616</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">100</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="57">57</biblScope>
<biblScope unit="page" to="70">70</biblScope>
</imprint>
<idno type="ISSN">1521-6616</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1521-6616</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>autoaggression</term>
<term>cyclosporine</term>
<term>vasculopathy</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Acute phase</term>
<term>Acute response</term>
<term>Adoptive</term>
<term>Adoptive transfer</term>
<term>Allograft</term>
<term>Allograft rejection</term>
<term>Assay</term>
<term>Atherosclerosis</term>
<term>Autoaggression</term>
<term>Autoimmune</term>
<term>Autoimmune recognition</term>
<term>Autoimmune vasculopathy</term>
<term>Autologous</term>
<term>Autoreactive</term>
<term>Bone marrow transplant</term>
<term>Cdr3</term>
<term>Cdr3 size</term>
<term>Cell repertoire</term>
<term>Chloroquine</term>
<term>Chloroquine treatment</term>
<term>Chronic allograft rejection</term>
<term>Chronic gvhd</term>
<term>Chronic phases</term>
<term>Chronic rejection</term>
<term>Chronic sgvhd</term>
<term>Clonal</term>
<term>Clonal expansion model</term>
<term>Control template</term>
<term>Control template signals</term>
<term>Cyclosporine</term>
<term>Cytokine</term>
<term>Cytokine mrna transcripts</term>
<term>Determinant</term>
<term>Effector</term>
<term>Effector spleen cells</term>
<term>Endothelial</term>
<term>Endothelial cells</term>
<term>Endothelialitis</term>
<term>Endothelium</term>
<term>Graft</term>
<term>Graft atherosclerosis</term>
<term>Graft vasculopathy</term>
<term>Grafted</term>
<term>Grafted heart</term>
<term>Grafted hearts</term>
<term>Grafted tissue</term>
<term>Growth factor beta</term>
<term>Gvhd</term>
<term>Heart graft</term>
<term>Heart grafts</term>
<term>Heart transplantation</term>
<term>Hess</term>
<term>Immunol</term>
<term>Initial onset</term>
<term>Invariant chain</term>
<term>Lesion</term>
<term>Lymphocyte</term>
<term>Major histocompatibility</term>
<term>Medial</term>
<term>Medial wall</term>
<term>Mrna</term>
<term>Mrna transcripts</term>
<term>Neointima</term>
<term>Neointima formation</term>
<term>Nontransplanted</term>
<term>Nontransplanted heart</term>
<term>Normal mouse serum</term>
<term>Prebleed rabbit</term>
<term>Present studies</term>
<term>Recent studies</term>
<term>Receptor</term>
<term>Sgvhd</term>
<term>Sgvhd effector</term>
<term>Sgvhd effector lymphocytes</term>
<term>Subset</term>
<term>Syngeneic</term>
<term>Syngeneic disease</term>
<term>Syngeneic heart graft</term>
<term>Syngeneic heart grafts</term>
<term>Syngeneic heart transplantation</term>
<term>Target antigen</term>
<term>Target cells</term>
<term>Transplant</term>
<term>Transplantation</term>
<term>Upregulation</term>
<term>Vascular</term>
<term>Vascular disease</term>
<term>Vascular endothelium</term>
<term>Vascular lesions</term>
<term>Vasculopathy</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: The use of the immunosuppressive drug cyclosporine A (CsA) in solid organ transplantation can be associated with the development of vasculopathy as part of the complex immune response involved in chronic rejection, including autoimmune recognition. Although CsA can directly affect endothelial cells, this drug alters the T cell repertoire promoting autoimmune recognition. The present studies evaluated the ability of CsA-induced autoreactive T cells to mediate vascular lesions in syngeneic heart grafts. Graft vasculopathy developed in syngeneic heart grafts following either the primary induction of autoimmunity with CsA or the adoptive transfer of CsA-induced autoreactive T cells. Initially, an inflammatory response occurred in the medial wall of the small arterial vessels, accompanied by a perivascular lymphocytic infiltrate (including a lymphocytic infiltrate into the myocardium), followed by progression of vascular disease with endothelial cell proliferation. The development and progression of vascular disease correlated with the cytokine profile of the infiltrating lymphocytes with type 1 cytokines detected early and type 2 cytokines detected as the disease progressed. Initiation of this response correlated with upregulation of the target antigen recognized by the CsA-induced autoreactive T cells, the MHC class II–invariant chain peptide complex. This antigen complex, when upregulated on endothelial cells by interferon, allowed effective targeting by the autoreactive T lymphocytes. Strategies to inhibit the upregulation of MHC class II antigens by treatment of the recipients with chloroquine truncated the disease process. The results of these studies suggest that CsA-induced autoreactive mechanisms can contribute to the development of graft vasculopathy.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Baldwin, William" sort="Baldwin, William" uniqKey="Baldwin W" first="William" last="Baldwin">William Baldwin</name>
<name sortKey="Chen, Weiran" sort="Chen, Weiran" uniqKey="Chen W" first="Weiran" last="Chen">Weiran Chen</name>
<name sortKey="Hess, Allan D" sort="Hess, Allan D" uniqKey="Hess A" first="Allan D." last="Hess">Allan D. Hess</name>
<name sortKey="Hruban, Ralph" sort="Hruban, Ralph" uniqKey="Hruban R" first="Ralph" last="Hruban">Ralph Hruban</name>
<name sortKey="Miura, Yuji" sort="Miura, Yuji" uniqKey="Miura Y" first="Yuji" last="Miura">Yuji Miura</name>
<name sortKey="Qian, Zhiping" sort="Qian, Zhiping" uniqKey="Qian Z" first="Zhiping" last="Qian">Zhiping Qian</name>
<name sortKey="Sommer, Matthias" sort="Sommer, Matthias" uniqKey="Sommer M" first="Matthias" last="Sommer">Matthias Sommer</name>
<name sortKey="Thoburn, Christopher J" sort="Thoburn, Christopher J" uniqKey="Thoburn C" first="Christopher J." last="Thoburn">Christopher J. Thoburn</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001138 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001138 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:42BD07AF7966E59DF1A7C5E2A04236F1F462F8EF
   |texte=   Autoimmune-Mediated Vasculopathy
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021